Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 111-120 of 9365

Page
per page
  1. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
     57 Citation
    Target: Ferroptosis
    Summary: ferroptosis inhibitor
      ≥149 mg/mL
  2. Paclitaxel (Taxol)
    A4393 Paclitaxel (Taxol)
     27 Citation
    Target: Microtubules/Tubulins
    Summary: microtubule depolymerization inhibitor
      ≥85.6 mg/mL
  3. Alarelin Acetate
    A3151 Alarelin Acetate
    Summary: Synthetic GnRH agonist
      ≥128.7 mg/mL
  4. Asunaprevir (BMS-650032)
    A3195 Asunaprevir (BMS-650032)
     5 Citation
    Summary: NS3 protease inhibitor
      ≥37.41 mg/mL
  5. DMH-1
    B3686 DMH-1
     2 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  6. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
     1 Citation
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC inhibitor
      ≥57.1 mg/mL
  7. Chlorambucil
    B3716 Chlorambucil
    Summary: nitrogen mustard alkylating agent
      insoluble in H2O; ≥12.15 mg/mL
  8. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  9. Bromocriptine mesylate
    B6298 Bromocriptine mesylate
    Summary: A potent, selective D2-like dopamine receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
  10. Melittin
    B6628 Melittin
    Summary: Inhibits Gs and stimulates Gi activity
      ≥114.6 mg/mL

Items 111-120 of 9365

Page
per page